share_log

HC Wainwright & Co. Reiterates Buy on HilleVax, Maintains $28 Price Target

Benzinga ·  Mar 21 06:27

HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment